nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ITGAL—Beta2 integrin cell surface interactions—TGFBI—osteoarthritis	0.0773	0.0773	CbGpPWpGaD
Lovastatin—ITGAL—Integrin cell surface interactions—COMP—osteoarthritis	0.0632	0.0632	CbGpPWpGaD
Lovastatin—ITGAL—Integrin cell surface interactions—COL9A2—osteoarthritis	0.0394	0.0394	CbGpPWpGaD
Lovastatin—ITGAL—Integrin cell surface interactions—COL9A1—osteoarthritis	0.0383	0.0383	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—ASPN—osteoarthritis	0.0363	0.0363	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MATN1—osteoarthritis	0.0363	0.0363	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MATN3—osteoarthritis	0.0363	0.0363	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—COMP—osteoarthritis	0.0271	0.0271	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—COMP—osteoarthritis	0.0208	0.0208	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—GDF5—osteoarthritis	0.0208	0.0208	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—FMOD—osteoarthritis	0.0199	0.0199	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—COL10A1—osteoarthritis	0.0177	0.0177	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—ADAMTS5—osteoarthritis	0.0167	0.0167	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—ADAMTS3—osteoarthritis	0.0167	0.0167	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—ADAMTS4—osteoarthritis	0.0142	0.0142	CbGpPWpGaD
Lovastatin—HDAC2—p75 NTR receptor-mediated signalling—MCF2L—osteoarthritis	0.0139	0.0139	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—COL2A1—osteoarthritis	0.0137	0.0137	CbGpPWpGaD
Lovastatin—ITGAL—Integrin cell surface interactions—FN1—osteoarthritis	0.0133	0.0133	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—SOX9—osteoarthritis	0.0132	0.0132	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—COL9A2—osteoarthritis	0.013	0.013	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—COL9A1—osteoarthritis	0.0126	0.0126	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—BGN—osteoarthritis	0.0111	0.0111	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—COL2A1—osteoarthritis	0.0105	0.0105	CbGpPWpGaD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—MMP1—osteoarthritis	0.0105	0.0105	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—CTSK—osteoarthritis	0.0102	0.0102	CbGpPWpGaD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—FN1—osteoarthritis	0.00959	0.00959	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP13—osteoarthritis	0.00896	0.00896	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—BMP2—osteoarthritis	0.00865	0.00865	CbGpPWpGaD
Lovastatin—UGT1A3—Phase II conjugation—GSTO1—osteoarthritis	0.00862	0.00862	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—TIMP1—osteoarthritis	0.00771	0.00771	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—PBRM1—osteoarthritis	0.00749	0.00749	CbGpPWpGaD
Lovastatin—UGT2B7—Phase II conjugation—GSTO1—osteoarthritis	0.00733	0.00733	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—BGLAP—osteoarthritis	0.00715	0.00715	CbGpPWpGaD
Lovastatin—CYP2C8—Arachidonic acid metabolism—PTGES—osteoarthritis	0.007	0.007	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—COL2A1—osteoarthritis	0.00699	0.00699	CbGpPWpGaD
Lovastatin—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.00681	0.00681	CbGpPWpGaD
Lovastatin—CYP2C19—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00624	0.00624	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP3—osteoarthritis	0.006	0.006	CbGpPWpGaD
Lovastatin—UGT1A1—Phase II conjugation—GSTO1—osteoarthritis	0.00595	0.00595	CbGpPWpGaD
Lovastatin—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00569	0.00569	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—FN1—osteoarthritis	0.00569	0.00569	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CTSK—osteoarthritis	0.00523	0.00523	CbGpPWpGaD
Lovastatin—HMGCR—AMPK Signaling—LEP—osteoarthritis	0.00522	0.00522	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—MCF2L—osteoarthritis	0.00511	0.00511	CbGpPWpGaD
Lovastatin—UGT1A3—Biological oxidations—GSTO1—osteoarthritis	0.00504	0.00504	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—IGF1—osteoarthritis	0.00499	0.00499	CbGpPWpGaD
Lovastatin—UGT1A3—Metapathway biotransformation—GSTO1—osteoarthritis	0.00497	0.00497	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—SMAD3—osteoarthritis	0.00494	0.00494	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—HSPA5—osteoarthritis	0.00481	0.00481	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP1—osteoarthritis	0.00479	0.00479	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—TIMP1—osteoarthritis	0.00458	0.00458	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—FN1—osteoarthritis	0.00438	0.00438	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—SMAD3—osteoarthritis	0.00429	0.00429	CbGpPWpGaD
Lovastatin—UGT2B7—Biological oxidations—GSTO1—osteoarthritis	0.00429	0.00429	CbGpPWpGaD
Lovastatin—UGT2B7—Metapathway biotransformation—GSTO1—osteoarthritis	0.00423	0.00423	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HSPA5—osteoarthritis	0.00416	0.00416	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—ESR1—osteoarthritis	0.00403	0.00403	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—MMP1—osteoarthritis	0.00376	0.00376	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.00375	0.00375	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP2—osteoarthritis	0.00371	0.00371	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—SMAD3—osteoarthritis	0.00357	0.00357	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoarthritis	0.0035	0.0035	CbGpPWpGaD
Lovastatin—UGT1A1—Biological oxidations—GSTO1—osteoarthritis	0.00348	0.00348	CbGpPWpGaD
Lovastatin—UGT1A1—Metapathway biotransformation—GSTO1—osteoarthritis	0.00344	0.00344	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00337	0.00337	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CTSK—osteoarthritis	0.00317	0.00317	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CAMK2B—osteoarthritis	0.00317	0.00317	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—osteoarthritis	0.00296	0.00296	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—GSTO1—osteoarthritis	0.00293	0.00293	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.00292	0.00292	CbGpPWpGaD
Lovastatin—CYP3A7—Metapathway biotransformation—GSTO1—osteoarthritis	0.00289	0.00289	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.00288	0.00288	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—MMP1—osteoarthritis	0.00285	0.00285	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP9—osteoarthritis	0.00279	0.00279	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.00272	0.00272	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.00266	0.00266	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—FN1—osteoarthritis	0.0026	0.0026	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.00259	0.00259	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HSPA5—osteoarthritis	0.00252	0.00252	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—osteoarthritis	0.00246	0.00246	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL1RN—osteoarthritis	0.00246	0.00246	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—CXCL8—osteoarthritis	0.00242	0.00242	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—TGFB1—osteoarthritis	0.0023	0.0023	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—IGF1—osteoarthritis	0.00228	0.00228	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—osteoarthritis	0.00223	0.00223	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—GSTO1—osteoarthritis	0.00212	0.00212	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—TGFB1—osteoarthritis	0.00209	0.00209	CbGpPWpGaD
Lovastatin—CYP3A5—Metapathway biotransformation—GSTO1—osteoarthritis	0.00209	0.00209	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00203	0.00203	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.00201	0.00201	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—TNF—osteoarthritis	0.00191	0.00191	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—MMP2—osteoarthritis	0.00189	0.00189	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.00188	0.00188	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—FMOD—osteoarthritis	0.00184	0.00184	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—GSTO1—osteoarthritis	0.00183	0.00183	CbGpPWpGaD
Lovastatin—CYP2C8—Metapathway biotransformation—GSTO1—osteoarthritis	0.00181	0.00181	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—LEP—osteoarthritis	0.00177	0.00177	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL1A—osteoarthritis	0.00177	0.00177	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FMOD—osteoarthritis	0.00176	0.00176	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00174	0.00174	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—GSTO1—osteoarthritis	0.00164	0.00164	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	0.00163	0.00163	CbGpPWpGaD
Lovastatin—CYP2C19—Metapathway biotransformation—GSTO1—osteoarthritis	0.00161	0.00161	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IHH—osteoarthritis	0.00157	0.00157	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—TGFB1—osteoarthritis	0.00151	0.00151	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—GSTO1—osteoarthritis	0.00151	0.00151	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGES—osteoarthritis	0.0015	0.0015	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—FMOD—osteoarthritis	0.0015	0.0015	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.00149	0.00149	CbGpPWpGaD
Lovastatin—CYP2D6—Metapathway biotransformation—GSTO1—osteoarthritis	0.00149	0.00149	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL1A—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—HSPA5—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CRP—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Lovastatin—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.00147	0.00147	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TIMP1—osteoarthritis	0.00141	0.00141	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	0.0014	0.0014	CbGpPWpGaD
Lovastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00137	0.00137	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—TGFB1—osteoarthritis	0.00137	0.00137	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL6—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—FMOD—osteoarthritis	0.00128	0.00128	CbGpPWpGaD
Lovastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00122	0.00122	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGES—osteoarthritis	0.00122	0.00122	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TGFBI—osteoarthritis	0.00117	0.00117	CbGpPWpGaD
Lovastatin—UGT1A3—NRF2 pathway—TGFB1—osteoarthritis	0.00116	0.00116	CbGpPWpGaD
Lovastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00112	0.00112	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—FMOD—osteoarthritis	0.00111	0.00111	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IHH—osteoarthritis	0.0011	0.0011	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MCF2L—osteoarthritis	0.0011	0.0011	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GSTO1—osteoarthritis	0.00106	0.00106	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGES—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—FMOD—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—BGN—osteoarthritis	0.00102	0.00102	CbGpPWpGaD
Lovastatin—HDAC2—Disease—GSTO1—osteoarthritis	0.00101	0.00101	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.001	0.001	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.000985	0.000985	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—TGFB1—osteoarthritis	0.000984	0.000984	CbGpPWpGaD
Lovastatin—HDAC2—Disease—BGN—osteoarthritis	0.000978	0.000978	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.000971	0.000971	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—FMOD—osteoarthritis	0.000951	0.000951	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL1B—osteoarthritis	0.000922	0.000922	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGES—osteoarthritis	0.000906	0.000906	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000892	0.000892	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—MMP1—osteoarthritis	0.000876	0.000876	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—FMOD—osteoarthritis	0.000872	0.000872	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GSTO1—osteoarthritis	0.000862	0.000862	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGES—osteoarthritis	0.000846	0.000846	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—BGN—osteoarthritis	0.000835	0.000835	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000814	0.000814	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—COL9A2—osteoarthritis	0.000805	0.000805	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	0.000804	0.000804	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—TGFB1—osteoarthritis	0.0008	0.0008	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—FN1—osteoarthritis	0.000799	0.000799	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—COL9A1—osteoarthritis	0.000782	0.000782	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—TGFB1—osteoarthritis	0.00078	0.00078	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGES—osteoarthritis	0.000775	0.000775	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL1B—osteoarthritis	0.000771	0.000771	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GSTO1—osteoarthritis	0.000733	0.000733	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGES—osteoarthritis	0.000711	0.000711	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—BGN—osteoarthritis	0.00071	0.00071	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IGF1—osteoarthritis	0.0007	0.0007	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—IL6—osteoarthritis	0.000662	0.000662	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000661	0.000661	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GSTO1—osteoarthritis	0.000638	0.000638	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—FMOD—osteoarthritis	0.000631	0.000631	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—BGN—osteoarthritis	0.000618	0.000618	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	0.000599	0.000599	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GSTO1—osteoarthritis	0.000596	0.000596	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—BGN—osteoarthritis	0.000577	0.000577	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00057	0.00057	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—osteoarthritis	0.00056	0.00056	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—FMOD—osteoarthritis	0.000546	0.000546	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GSTO1—osteoarthritis	0.000546	0.000546	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL6—osteoarthritis	0.00054	0.00054	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—BMP2—osteoarthritis	0.000536	0.000536	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—BGN—osteoarthritis	0.000529	0.000529	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—SMAD3—osteoarthritis	0.000517	0.000517	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGES—osteoarthritis	0.000514	0.000514	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTO1—osteoarthritis	0.000501	0.000501	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—IL6—osteoarthritis	0.000499	0.000499	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000493	0.000493	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—FMOD—osteoarthritis	0.000488	0.000488	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—BGN—osteoarthritis	0.000485	0.000485	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SMAD3—osteoarthritis	0.00048	0.00048	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—FMOD—osteoarthritis	0.000476	0.000476	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—FMOD—osteoarthritis	0.000448	0.000448	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGES—osteoarthritis	0.000445	0.000445	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—FMOD—osteoarthritis	0.000445	0.000445	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—ESR1—osteoarthritis	0.000422	0.000422	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TGFB1—osteoarthritis	0.00042	0.00042	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000409	0.000409	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000399	0.000399	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGES—osteoarthritis	0.000397	0.000397	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGES—osteoarthritis	0.000388	0.000388	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP3—osteoarthritis	0.000371	0.000371	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGES—osteoarthritis	0.000366	0.000366	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGES—osteoarthritis	0.000362	0.000362	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTO1—osteoarthritis	0.000362	0.000362	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—BGN—osteoarthritis	0.000351	0.000351	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000341	0.000341	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SMAD3—osteoarthritis	0.000336	0.000336	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTO1—osteoarthritis	0.000314	0.000314	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—BGN—osteoarthritis	0.000304	0.000304	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000296	0.000296	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGS2—osteoarthritis	0.000295	0.000295	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000293	0.000293	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—LEP—osteoarthritis	0.000287	0.000287	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTGS2—osteoarthritis	0.000281	0.000281	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTO1—osteoarthritis	0.00028	0.00028	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000276	0.000276	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ESR1—osteoarthritis	0.000274	0.000274	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTO1—osteoarthritis	0.000273	0.000273	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—BGN—osteoarthritis	0.000271	0.000271	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FN1—osteoarthritis	0.000271	0.000271	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—BGN—osteoarthritis	0.000265	0.000265	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTO1—osteoarthritis	0.000258	0.000258	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTO1—osteoarthritis	0.000255	0.000255	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—BGN—osteoarthritis	0.000249	0.000249	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—BGN—osteoarthritis	0.000247	0.000247	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—osteoarthritis	0.00024	0.00024	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000239	0.000239	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IGF1—osteoarthritis	0.000237	0.000237	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—osteoarthritis	0.000204	0.000204	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TGFB1—osteoarthritis	0.000203	0.000203	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000196	0.000196	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—osteoarthritis	0.000191	0.000191	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—osteoarthritis	0.000178	0.000178	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000175	0.000175	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—osteoarthritis	0.000173	0.000173	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.000168	0.000168	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—osteoarthritis	0.000166	0.000166	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BGN—osteoarthritis	0.000163	0.000163	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00016	0.00016	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—osteoarthritis	0.000153	0.000153	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—osteoarthritis	0.000152	0.000152	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—osteoarthritis	0.000142	0.000142	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—osteoarthritis	0.00014	0.00014	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—osteoarthritis	0.000107	0.000107	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—osteoarthritis	0.000101	0.000101	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—osteoarthritis	8.73e-05	8.73e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—osteoarthritis	7.8e-05	7.8e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—osteoarthritis	7.61e-05	7.61e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—osteoarthritis	7.17e-05	7.17e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—osteoarthritis	7.11e-05	7.11e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—osteoarthritis	4.69e-05	4.69e-05	CbGpPWpGaD
